Brainomix

Brainomix is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 5 investors associated with the company.

Brainomix is an Oxford-based company that develops and markets artificial intelligence (AI) powered medical imaging software. Their suite of tools are designed to improve clinical decision-making for stroke and other neurological conditions, enabling faster treatment and better patient outcomes.